Study 1TNFA expression (inflammation)COL1A1 expression (fibrosis)CD31 expression (vascularity)Study 2Major adverse cardiovascular events (composite endpoint of cardiac mortality and non-fatal myocardial infarction)Study 3Acute myocardial infarction vs. stable CAD. Here, PECAM1 is linked to coronary artery disorder.